Recently added

Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes

Johansson, Erin; ZIMNER RAPUCH, Sarah; Dimitriadis, Georgios K. ; Bertrand, Marine; Curteis, Tristan; Ciudin Mihai, Andreea (Wiley, 2025-09)

Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis

Szymczak, Wendy; Engsbro, Anne Line; Lisby, Jan Gorm; Granato, Paul; Ledeboer, Nathan; González-López, Juan José (American Society for Microbiology, 2025-08)

Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab

Vargas Brochero, Maria Jose; Lafaut, Elisabeth; Radhakrishnan, Yeshwanter; Russo, Ilario; Sethi, Sanjeev; Zand, Ladan; Soler, María José (Elsevier, 2025-08)

Role of VATS-US in identifying and characterizing pulmonary nodules: a narrative review

Grao Roca, María; Vivas, Juan-Camilo; Jauregui, Alberto; Gonzalez Suarez, Susana (Frontiers Media, 2025-05-20)

Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study

Mayo de las Casas, Clara; Jantus Lewintre, Eloisa; Ortiz Reina, Sebastián; Drozdowskyj, Ana; Cerezuela-Fuentes, Pablo; MANZANO, JOSE LUIS; MUÑOZ COUSELO, EVA (Elsevier, 2025)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Institut Català de la Salut - ICS: Recent submissions

Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes

Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis

Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab

Role of VATS-US in identifying and characterizing pulmonary nodules: a narrative review

Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Institut Català de la Salut - ICS: Recent submissions

Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes ﻿

Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis ﻿

Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab ﻿

Role of VATS-US in identifying and characterizing pulmonary nodules: a narrative review ﻿

Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study ﻿

Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes

Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis

Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab

Role of VATS-US in identifying and characterizing pulmonary nodules: a narrative review

Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study